Product
Vero cell derived inactive Japanese encephalitis vaccine
1 clinical trial
4 indications
Indication
Japanese EncephalitisIndication
MeaslesIndication
MumpsIndication
RubellaClinical trial
A Phase Ⅳ, Randomized, Controlled, Open-label, Immunogenicity Study of Vero Cell-derived Inactivated Japanese Encephalitis Vaccine (JEV-I) Co-administered With Measles-Mumps-Rubella Vaccine (MMR)Status: Recruiting, Estimated PCD: 2024-09-30